AXIM BIOTECHNOLOGIES, INC. Amortization
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Amortization of $42.86 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2024-04-16
- AXIM BIOTECHNOLOGIES, INC. amortization for the quarter ending 2023-12-31 was -$55.75K.
- AXIM BIOTECHNOLOGIES, INC. amortization for the quarter ending 2023-09-30 was $98.61K, a 66.67% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization for the quarter ending 2023-06-30 was $98.61K, a 0.00% change year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization for the quarter ending 2023-03-31 was $98.61K, a 0.00% change year-over-year.
- AXIM BIOTECHNOLOGIES, INC. amortization for fiscal 2023 was $42.86K, a 79.60% decline from fiscal 2022.
- AXIM BIOTECHNOLOGIES, INC. amortization for fiscal 2022 was $210.09K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$55.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $42.86K derived: sum of 2 quarters · filed 2024-04-16 | $141.47K derived: sum of 3 quarters · filed 2024-04-16 | $42.86K 10-K · filed 2024-04-16 |
| 2023-09-30 | $98.61K 10-Q · filed 2023-11-20 | $197.22K derived: sum of 2 quarters · filed 2023-11-20 | $98.61K 10-Q · filed 2023-11-20 | $210.09K derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-06-30 | $98.61K 10-Q · filed 2023-08-21 | $197.22K 10-Q · filed 2023-08-21 | $111.48K derived: sum of 3 quarters · filed 2024-04-16 | $407.32K derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-03-31 | $98.61K 10-Q · filed 2023-05-22 | $12.87K derived: sum of 2 quarters · filed 2024-04-16 | $308.71K derived: sum of 3 quarters · filed 2024-04-16 | $407.32K derived: sum of 4 quarters · filed 2024-04-16 |
| 2022-12-31 | -$85.74K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $210.09K derived: sum of 2 quarters · filed 2024-04-16 | $308.71K derived: sum of 3 quarters · filed 2024-04-16 | $210.09K 10-K · filed 2024-04-16 |
| 2022-09-30 | $295.84K 10-Q · filed 2023-11-20 | $394.45K derived: sum of 2 quarters · filed 2023-11-20 | $295.84K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $98.61K 10-Q · filed 2023-08-21 | $197.22K 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $98.61K 10-Q · filed 2023-05-22 |